Evidence map›Paper›PMID 37979010›Full record

ArticleCancer immunology, immunotherapy : CII2023

Correction to: Extended duration of treatment using reduced‑frequency dosing of anti‑PD‑1 therapy in patients with advanced melanoma and Merkel cell carcinoma.

Lisa May Ling Tachiki, Daniel S Hippe, Karly Williams Silva, Evan Thomas Hall, William McCamy, Dane Fritzsche, Andrea Perdue, Julia Majovski, Thomas Pulliam, Daniel A Goldstein and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer immunology, immunotherapy : CII, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Lisa May Ling TachikiDepartment of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA. ltachiki@uw.edu.ORCID http://orcid.org/0000-0001-8057-8029
Daniel S HippeClinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Karly Williams SilvaDepartment of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
Evan Thomas HallDepartment of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
William McCamyDepartment of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
Dane FritzscheClinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Andrea PerdueDepartment of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
Julia MajovskiDepartment of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
Thomas PulliamDepartment of Medicine, Division of Dermatology, University of Washington, Seattle, WA, USA.
Daniel A GoldsteinDavidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.
Joshua VeatchDepartment of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
Joel HoDepartment of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
Paul T NghiemDepartment of Medicine, Division of Dermatology, University of Washington, Seattle, WA, USA.
John A ThompsonDepartment of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
Shailender BhatiaDepartment of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA. sbhatia@uw.edu.ORCID http://orcid.org/0000-0002-3816-2238

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37979010
PMCPMC10700449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.